FEDERAL HEALTH POLICY STRATEGIES lobbying for KIDNEY CARE PARTNERS

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.

Health Issues

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.

Bills named in this filing 4

H.R. 2199
Restore Protections for Dialysis Patients Act
S. 1173
Restore Protections for Dialysis Patients Act
H.R. 6214
Kidney Care Access Protection Act
S. 2730
Kidney Care Access Protection Act